NCT02203552 2025-01-08
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
9 trialsNCT01283997 2024-06-13
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02297412 2022-01-31
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Academic and Community Cancer Research United
Phase 2 Completed
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01173692 2021-08-20
Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01636934 2020-07-17
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01906008 2020-03-17
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01693523 2020-03-09
Minocycline Study in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed